Picture of Neuroscientific Biopharmaceuticals logo

NSB Neuroscientific Biopharmaceuticals News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO

July 28 (Reuters) - NeuroScientific Biopharmaceuticals Ltd NSB.AX:

EXPERIENCED CELL THERAPY EXECUTIVE APPOINTED CEO

APPOINTS NATHAN SMITH AS CEO

Further company coverage: NSB.AX

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Neuroscientific Biopharmaceuticals

See all news